This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Medtronic, Inc.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Michael P Frenneaux: Innovator in Cardiac Pacing Technology
Introduction
Michael P Frenneaux is a notable inventor based in Kincardineshire, GB. He has made significant contributions to the field of cardiac pacing technology, particularly in the area of ventricular dyssynchrony. His innovative approach has the potential to improve the quality of life for patients with heart conditions.
Latest Patents
Michael P Frenneaux holds a patent for "Pacing interval determination for ventricular dyssynchrony." This patent involves a left-ventricular pacing interval and a right-ventricular pacing interval for timing the delivery of pacing pulses to the left and right ventricles of the heart. The pacing intervals are based on intrinsic conduction time intervals between atrial and ventricular events, allowing for more precise pacing that can enhance cardiac function.
Career Highlights
Throughout his career, Frenneaux has been associated with Medtronic, Inc., a leading company in medical technology. His work has focused on developing advanced pacing techniques that address the complexities of heart rhythm management. With 1 patent to his name, he has established himself as a key player in the field of cardiac innovation.
Collaborations
Michael has collaborated with notable professionals in the industry, including Vinayakrishnan Rajan and Berthold Stegemann. These collaborations have contributed to the advancement of cardiac pacing technologies and have fostered a spirit of innovation within the field.
Conclusion
Michael P Frenneaux is a distinguished inventor whose work in cardiac pacing technology has the potential to transform patient care. His innovative patent addresses critical aspects of ventricular dyssynchrony, showcasing his commitment to improving heart health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile